This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeVoti, J. A.
Right arrow Articles by Bonagura, V. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeVoti, J. A.
Right arrow Articles by Bonagura, V. R.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, May 2004, p. 538-547, Vol. 11, No. 3
1071-412X/04/$08.00+0     DOI: 10.1128/CDLI.11.3.538-547.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Failure of Gamma Interferon but Not Interleukin-10 Expression in Response to Human Papillomavirus Type 11 E6 Protein in Respiratory Papillomatosis

James A. DeVoti,1 Bettie M. Steinberg,2 David W. Rosenthal,1 Lynda Hatam,1 Andrea Vambutas,2 Allan L. Abramson,2 Mark J. Shikowitz,2 and Vincent R. Bonagura1*

Division of Allergy and Immunology, Department of Pediatrics,1 Department of Otolaryngology and Communicative Disorders, Long Island Jewish Medical Center and North Shore Long-Island Jewish Research Institute, New Hyde Park, New York 110402

Received 6 November 2003/ Returned for modification 29 December 2003/ Accepted 26 February 2004

Recurrent respiratory papillomatosis (RRP) is a chronic, debilitating disease of the upper airway caused by human papillomavirus type 6 (HPV-6) or HPV-11. We describe responses of peripheral blood mononuclear cells (PBMC) and T cells from RRP patients and controls to the HPV-11 early proteins E6 and E7. PBMC were exposed in vitro to purified E6 or E7 proteins or transduced with fusion proteins containing the first 11 amino acids of the human immunodeficiency virus type 1 protein tat fused to E6 or E7 (tat-E6/tat-E7). TH1-like (interleukin-2 [IL-2], gamma interferon [IFN-{gamma}], IL-12, and IL-18), and TH2-like (IL-4 and IL-10) cytokine mRNAs were identified by reverse transcription-PCR, and IFN-{gamma} and IL-10 cytokine-producing cells were identified by enzyme-linked immunospot assay. These studies show that HPV-11 E6 skews IL-10-IFN-{gamma} expression by patients with RRP toward greater expression of IL-10 than of IFN-{gamma}. In addition, there is a general cytokine hyporesponsiveness to E6 that is more prominent for TH1-like cytokine expression by patients with severe disease. Patients showed persistent IL-10 cytokine expression by the nonadherent fraction of PBMC when challenged with E6 and tat-E6, and, in contrast to controls, both T cells and non-T cells from patients expressed IL-10. However, E7/tat-E7 cytokine responses in patients with RRP were similar to those of the controls. In contrast, E6 inhibited IL-2 and IL-18 mRNA expression that would further contribute to a cytokine microenvironment unfavorable to HPV-specific, T-cell responses that should control persistent HPV infection. In summary, E6 is the dominant inducer of cytokine expression in RRP, and it induces a skewed expression of IL-10 compared to the expression of IFN-{gamma}.

* Corresponding author. Mailing address: 410 Lakeville Rd., Ste. 108, New Hyde Park, NY 11042. Phone: (516) 465-5361. Fax: (516) 465-5385. E-mail: bonagura{at}lij.edu.

Clinical and Diagnostic Laboratory Immunology, May 2004, p. 538-547, Vol. 11, No. 3
1071-412X/04/$08.00+0     DOI: 10.1128/CDLI.11.3.538-547.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Shikowitz, M. J., Abramson, A. L., Steinberg, B. M., DeVoti, J., Bonagura, V. R., Mullooly, V., Nouri, M., Ronn, A. M., Inglis, A., McClay, J., Freeman, K. (2005). Clinical Trial of Photodynamic Therapy With Meso-Tetra (Hydroxyphenyl) Chlorin for Respiratory Papillomatosis. Arch Otolaryngol Head Neck Surg 131: 99-105 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»